FAQ

Flebogamma

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
02420032016

Related topics

Related topics

2 relations

Broader (2)

Immunoglobulin GImmunoglobulin G, Human

Related mentions per year

Related mentions per year

1950-2018
1960198020002020
Flebogamma
Immunoglobulin G
Immunoglobulin G, Human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
The previous studies with Flebogamma® 5 % DIF intravenous immunoglobulin (IVIG) contained insufficient numbers of pediatric… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Specific binding of intravenous immunoglobulin products to tau peptide fragments.
The effects of intravenous immunoglobulin (IVIG) products are being evaluated in Alzheimer's disease (AD) patients. IVIG contains… (More)
Is this relevant?
2013
2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein.
Intravenous immunoglobulin (IVIG) products are prepared from plasma immunoglobulins from healthy donors. Pilot studies suggest… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Direct medical costs of liquid intravenous immunoglobulins in children, adolescents, and adults in Spain.
The aim of this study was to determine health care resource utilization and direct medical costs in Spanish patients treated with… (More)
Is this relevant?
2011
2011
Pasteurization Inactivates Clotting Enzymes During Flebogamma? And Flebogamma? Dif Production
  • Maite L Ristol P Jorquera
  • 2011
Background:A recent thromboembolic adverse events outbreak linked to a specific intravenous immunoglobulin (IVIG) brand has… (More)
Is this relevant?
2010
2010
Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations.
Cognitive improvement in Alzheimer's disease (AD) patients treated with intravenous immunoglobulin (IvIg) has been attributed to… (More)
Is this relevant?
2009
2009
Flebogamma 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy.
Flebogamma 5% dual inactivation and filtration (DIF), a new 5% liquid intravenous immunoglobulin with a stability of 2 years when… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?
2009
2009
Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.
The development of effective, safe, liquid intravenous immunoglobulins (IVIG) preparations has represented a major therapeutic… (More)
Is this relevant?
2004
2004
Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.
Antibodies directed against human respiratory syncytial virus (HRSV) from two commercial preparations of human immunoglobulins… (More)
Is this relevant?
2003
2003
Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.
Although atopic dermatitis generally responds to topical therapy, small numbers of patients have severe resistant disease despite… (More)
Is this relevant?